The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

DSE:IBNSINA Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 16, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	9,154	7,805	8,954	9,270	7,708	7,002
Market Cap Growth	0.07%	-12.84%	-3.40%	20.27%	10.08%	-15.15%
Enterprise Value	10,524	8,919	9,692	9,892	8,398	7,847
Last Close Price	293.00	244.69	274.85	278.97	228.05	203.91
PE Ratio	15.42	11.64	14.79	15.30	15.76	17.84
PS Ratio	0.80	0.69	0.98	1.09	1.05	1.13
PB Ratio	2.52	2.21	2.93	3.53	3.59	3.94
P/TBV Ratio	2.55	2.23	2.96	3.56	3.59	3.94
P/FCF Ratio	191.16	-	18.93	173.59	24.89	-
P/OCF Ratio	14.48	17.78	9.97	22.15	13.96	14.07
EV/Sales Ratio	0.92	0.78	1.06	1.17	1.14	1.27
EV/EBITDA Ratio	6.21	5.09	6.22	9.69	9.11	10.52
EV/EBIT Ratio	12.50	9.75	11.82	12.05	11.46	13.09
EV/FCF Ratio	219.77	-	20.49	185.25	27.12	-
Debt / Equity Ratio	0.47	0.53	0.32	0.41	0.40	0.54
Debt / EBITDA Ratio	1.01	1.06	0.62	1.02	0.91	1.25
Debt / FCF Ratio	35.82	-	2.09	20.02	2.80	-
Asset Turnover	1.84	1.98	1.96	2.08	2.03	1.98
Inventory Turnover	4.63	4.99	4.86	5.49	6.00	6.17
Quick Ratio	0.25	0.25	0.23	0.35	0.27	0.17
Current Ratio	1.14	1.13	1.26	1.46	1.26	0.83
Return on Equity (ROE)	17.31%	20.38%	21.33%	25.37%	24.91%	24.12%
Return on Assets (ROA)	8.44%	9.93%	11.00%	12.59%	12.58%	11.96%
Return on Capital (ROIC)	10.65%	12.08%	13.24%	15.30%	15.90%	15.24%
Return on Capital Employed (ROCE)	18.80%	21.80%	23.10%	25.80%	27.20%	28.00%
Earnings Yield	648.66%	8.59%	6.76%	6.54%	6.35%	5.61%
FCF Yield	52.31%	-2.24%	5.28%	0.58%	4.02%	-1.64%
Dividend Yield	212.19%	2.57%	2.18%	2.15%	2.06%	1.89%
Payout Ratio	3239.23%	26.83%	29.49%	29.28%	26.89%	22.16%
Total Shareholder Return	212.19%	2.57%	2.18%	2.15%	2.06%	1.89%

Updated Jan 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.